Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (27 quarters reported)
$257M in Q4 2019 → $2.53B now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Revolution Medicines Inc | 11.1% | Unchanged | 1,500,000 | $281M |
| Insmed Inc | 6.7% | Added 6.7% | 1,600,000 | $171M |
| Cytokinetics Inc | 5.4% | Unchanged | 1,600,000 | $136M |
| Cvs Health Corp | 4.5% | Added 633% | 1,100,000 | $114M |
| Edgewise Therapeutics Inc | 3.2% | Added 25% | 2,000,000 | $81.3M |
| Vera Therapeutics Inc | 3.0% | Added 9.4% | 1,750,000 | $75.1M |
| Axsome Therapeutics Inc. | 2.9% | Added 757% | 300,000 | $73.4M |
| Cardinal Health Inc | 2.8% | Added 11% | 300,000 | $71.3M |
| Roivant Sciences Ltd | 2.8% | Unchanged | 2,000,000 | $70.8M |
| Rhythm Pharmaceuticals Inc | 2.4% | Trimmed 8.3% | 550,000 | $61.1M |
| Edwards Lifesciences Corp | 2.2% | Added 268% | 625,000 | $56.5M |
| Revolution Medicines Inc Put | 2.2% | Trimmed 60% | 300,000 | $56.2M |
| Alignment Healthcare Inc | 1.9% | Trimmed 22% | 2,000,000 | $47.6M |
| Merck & Co Inc | 1.8% | Trimmed 18% | 350,000 | $45M |
| Quest Diagnostics Inc | 1.7% | Added 233% | 200,000 | $42.4M |
| UN Uniqure Nv | 1.6% | Unchanged | 900,000 | $41.5M |
| SR Scholar Rock Hldg Corp | 1.6% | Added 50% | 750,000 | $41.3M |
| Boston Scientific Corp | 1.5% | Added 64% | 900,000 | $38.4M |
| BH Brightspring Health Svcs Inc | 1.5% | Trimmed 56% | 550,000 | $38.4M |
| Abbott Laboratories | 1.4% | New | 400,000 | $36.3M |
| Unitedhealth Group Inc | 1.4% | New | 85,000 | $35.3M |
| Lifestance Health Group Inc | 1.3% | Trimmed 30% | 3,000,000 | $32.1M |
| Novartis Ag | 1.2% | Trimmed 20% | 200,000 | $31.3M |
| Tango Therapeutics Inc | 1.2% | Added 122% | 1,000,000 | $31.3M |
| Tenet Healthcare Corp | 1.2% | New | 165,000 | $30.9M |
| Spyre Therapeutics Inc | 1.1% | New | 325,000 | $28.9M |
| NA Novo-nordisk A S | 1.1% | New | 600,000 | $28.8M |
| Definium Therapeutics Inc | 1.0% | Added 38% | 550,000 | $25.9M |
| Neurocrine Biosciences Inc | 1.0% | Unchanged | 150,000 | $25.3M |
| Regeneron Pharmaceuticals | 1.0% | Trimmed 53% | 40,000 | $24.9M |
| Ionis Pharmaceuticals Inc Call | 0.9% | New | 300,000 | $23.8M |
| Biogen Inc | 0.9% | Added 67% | 100,000 | $21.6M |
| Travere Therapeutics Inc | 0.8% | New | 375,000 | $21.3M |
| LH Lantheus Hldgs Inc | 0.8% | Added 52% | 190,000 | $21.1M |
| Glaukos Corp | 0.8% | Trimmed 14% | 150,000 | $21M |
| Oric Pharmaceuticals Inc | 0.8% | Added 36% | 1,900,000 | $20.6M |
| Bridgebio Pharma Inc | 0.8% | Unchanged | 275,000 | $20.5M |
| Vertex Pharmaceuticals Inc | 0.8% | Unchanged | 40,000 | $19.9M |
| Alumis Inc | 0.8% | Trimmed 13% | 700,000 | $19.7M |
| EH Elevance Health Inc Formerly | 0.8% | Trimmed 33% | 50,000 | $19.3M |
| CD Centene Corp Del | 0.8% | Trimmed 54% | 300,000 | $19.3M |
| Erasca Inc | 0.7% | Added 43% | 1,000,000 | $18.3M |
| EL Eli Lilly & Co | 0.7% | Unchanged | 15,000 | $18M |
| AP Arrowhead Pharmaceuticals In | 0.6% | Trimmed 33% | 200,000 | $16.3M |
| Envista Holdings Corporation | 0.6% | Added 71% | 600,000 | $15.8M |
| Medtronic PLC | 0.6% | New | 200,000 | $15.6M |
| Waters Corp | 0.6% | New | 40,000 | $15M |
| Livanova PLC | 0.6% | Added 20% | 180,000 | $14.8M |
| NA Novo-nordisk A S Call | 0.6% | New | 300,000 | $14.4M |
| Forte Biosciences Inc | 0.6% | Added 350% | 675,000 | $14.3M |
| Madrigal Pharmaceuticals Inc | 0.5% | Unchanged | 25,000 | $13.4M |
| PP Praxis Precision Medicines I | 0.5% | Unchanged | 40,000 | $13.4M |
| Alto Neuroscience Inc | 0.5% | Unchanged | 500,000 | $13.2M |
| Mineralys Therapeutics Inc | 0.5% | Trimmed 40% | 450,000 | $12.1M |
| Xenon Pharmaceuticals Inc | 0.5% | Unchanged | 200,000 | $12.1M |
| Ascendis Pharma A/s | 0.5% | New | 45,000 | $12M |
| AH Acadia Healthcare Company In | 0.5% | Added 100% | 400,000 | $11.8M |
| Irhythm Holdings Inc | 0.4% | New | 90,000 | $10.7M |
| Biohaven Ltd | 0.4% | Trimmed 30% | 700,000 | $10.4M |
| Beam Therapeutics Inc | 0.4% | Unchanged | 300,000 | $10.3M |
Showing top 60 of 92 positions.
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cvs Health Corp | Added | +950,000 | +$98.3M | 4.5% |
| Revolution Medicines Inc | Trimmed | −450,000 | −$84.3M | 2.2% |
| Cytokinetics Inc | Exited | −1,000,000 | −$65.9M | — |
| Axsome Therapeutics Inc. | Added | +265,000 | +$64.9M | 2.9% |
| Astrazeneca PLC | Exited | −250,000 | −$49.3M | — |
| BH Brightspring Health Svcs Inc | Trimmed | −700,000 | −$48.8M | 1.5% |
| Revolution Medicines Inc | Exited | −500,000 | −$48.6M | — |
| Edwards Lifesciences Corp | Added | +455,000 | +$41.2M | 2.2% |
| Abbott Laboratories | New | +400,000 | +$36.3M | 1.4% |
| Unitedhealth Group Inc | New | +85,000 | +$35.3M | 1.4% |
Showing the 10 largest of 104 changes.
quarter ended March 31, 2026 · filed May 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Revolution Medicines Inc | New | +750,000 | +$72.9M | 3.5% |
| Medtronic PLC | Exited | −675,000 | −$64.8M | — |
| Astrazeneca PLC | New | +250,000 | +$49.3M | 2.4% |
| Revolution Medicines Inc | New | +500,000 | +$48.6M | 2.3% |
| Insmed Inc | Added | +250,000 | +$40.9M | 11.7% |
| Intuitive Surgical Inc | Trimmed | −75,000 | −$34.6M | 0.8% |
| Cytokinetics Inc | Added | +500,000 | +$33M | 3.2% |
| Astrazeneca PLC | Exited | −350,000 | −$32.2M | — |
| Roivant Sciences Ltd | Added | +1,150,000 | +$31.9M | 2.6% |
| TP Teva Pharmaceutical Inds Ltd | Exited | −1,000,000 | −$31.2M | — |
Showing the 10 largest of 104 changes.
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Revolution Medicines Inc | Added | +800,000 | +$63.7M | 4.7% |
| Insmed Inc | Trimmed | −350,000 | −$60.9M | 10.8% |
| Medtronic PLC | Added | +525,000 | +$50.4M | 3.2% |
| Intuitive Surgical Inc | Added | +85,000 | +$48.1M | 3.1% |
| Regeneron Pharmaceuticals | Added | +55,000 | +$42.5M | 4.0% |
| Tenet Healthcare Corp | Trimmed | −200,000 | −$39.7M | 1.0% |
| Dexcom Inc | New | +500,000 | +$33.2M | 1.6% |
| TP Teva Pharmaceutical Inds Ltd | New | +1,000,000 | +$31.2M | 1.5% |
| Teleflex Incorporated | New | +250,000 | +$30.5M | 1.5% |
| NP Newamsterdam Pharma Company | Exited | −1,000,000 | −$28.4M | — |
Showing the 10 largest of 92 changes.
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Mineralys Therapeutics Inc | Trimmed | −1,200,000 | −$45.5M | 3.8% |
| UN Uniqure Nv | Trimmed | −750,000 | −$43.8M | 2.4% |
| NP Newamsterdam Pharma Company | New | +1,000,000 | +$28.4M | 1.9% |
| Boston Scientific Corp | Trimmed | −250,000 | −$24.4M | 2.0% |
| NA Novo-nordisk A S | New | +400,000 | +$22.2M | 1.5% |
| Cytokinetics Inc | Added | +400,000 | +$22M | 5.2% |
| Alignment Healthcare Inc | Added | +1,200,000 | +$20.9M | 1.9% |
| Dexcom Inc | Exited | −200,000 | −$17.5M | — |
| Vera Therapeutics Inc | Added | +550,000 | +$16M | 3.3% |
| Encompass Health Corp | Trimmed | −120,000 | −$15.2M | 1.7% |
Showing the 10 largest of 83 changes.
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Quest Diagnostics Inc | New | +150,000 | +$26.9M | 2.5% |
| Regeneron Pharmaceuticals | New | +50,000 | +$26.3M | 2.4% |
| Cardinal Health Inc | New | +140,000 | +$23.5M | 2.2% |
| Gilead Sciences Inc | Exited | −175,000 | −$19.6M | — |
| EL Eli Lilly & Co | New | +25,000 | +$19.5M | 1.8% |
| CR Charles Riv Labs Intl Inc | New | +115,000 | +$17.4M | 1.6% |
| Cytokinetics Inc | New | +500,000 | +$16.5M | 1.5% |
| Ascendis Pharma A/s | Exited | −100,000 | −$15.6M | — |
| Astrazeneca PLC | New | +200,000 | +$14M | 1.3% |
| Arcellx Inc | Exited | −200,000 | −$13.1M | — |
Showing the 10 largest of 87 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Insmed Inc | Exited | −500,000 | −$34.5M | — |
| CD Centene Corp Del | Exited | −500,000 | −$30.3M | — |
| Cardinal Health Inc | Exited | −250,000 | −$29.6M | — |
| EL Eli Lilly & Co | Exited | −38,000 | −$29.3M | — |
| Elevance Health Inc | New | +65,000 | +$28.3M | 3.0% |
| Novartis Ag | New | +250,000 | +$27.9M | 3.0% |
| Mineralys Therapeutics Inc | Added | +1,425,000 | +$22.6M | 3.9% |
| Intuitive Surgical Inc | Exited | −40,000 | −$20.9M | — |
| Cvs Health Corp | Trimmed | −300,000 | −$20.3M | 1.4% |
| Merck & Co Inc | Exited | −200,000 | −$19.9M | — |
Showing the 10 largest of 105 changes.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| LP Longboard Pharmaceuticals In | Exited | −1,050,000 | −$35M | — |
| Insmed Inc | New | +500,000 | +$34.5M | 2.9% |
| CD Centene Corp Del | New | +500,000 | +$30.3M | 2.6% |
| Cardinal Health Inc | New | +250,000 | +$29.6M | 2.5% |
| Vera Therapeutics Inc | Added | +650,000 | +$27.5M | 4.1% |
| Novartis Ag | Exited | −200,000 | −$23M | — |
| Cvs Health Corp | New | +500,000 | +$22.4M | 1.9% |
| Neurocrine Biosciences Inc | New | +160,000 | +$21.8M | 1.9% |
| EL Eli Lilly & Co | Added | +28,000 | +$21.6M | 2.5% |
| Intuitive Surgical Inc | New | +40,000 | +$20.9M | 1.8% |
Showing the 10 largest of 97 changes.
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Elevance Health Inc | Exited | −80,000 | −$43.3M | — |
| IM Inspire Med Sys Inc | New | +160,000 | +$33.8M | 3.8% |
| Humana Inc | Exited | −75,000 | −$28M | — |
| Medtronic PLC | New | +300,000 | +$27M | 3.0% |
| UH Universal Hlth Svcs Inc | Exited | −130,000 | −$24M | — |
| Ionis Pharmaceuticals Inc | Exited | −500,000 | −$23.8M | — |
| BD Becton Dickinson & Co | Exited | −75,000 | −$17.5M | — |
| The Cigna Group | Exited | −50,000 | −$16.5M | — |
| Krystal Biotech Inc | Exited | −85,000 | −$15.6M | — |
| Icon PLC | Exited | −45,000 | −$14.1M | — |
Showing the 10 largest of 95 changes.
Loading...
